Cohance Lifesciences Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹460Market Cap
₹ 17,588 Cr.Stock P/E
163ROE
4.89 %RSI
63.17Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Cohance Lifesciences is a Hyderabad-based CDMO operating across pharmaceutical development, manufacturing, APIs, formulations and specialty chemicals. The company states that it features among the Top 20 CDMOs globally; its Pharma CDMO business works with 19 of the top 20 global innovators, while the API portfolio ranks among the top three suppliers in 8 of its top 10 molecules.[1][2]
Cohance Lifesciences Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Cohance Lifesciences Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Cohance Lifesciences Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 460 |
| RSI (14) | 63.17 |
| 50 DMA | 444.87 |
| 200 DMA | 427.05 |
| Trend | Bullish |
| A/D Rating | A+ |
| RS Rating | 42 |
| EPS Rating | 5 |
| TI65 | 1.03 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Cohance Lifesciences Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹494.16 |
| R2 | ₹485.33 |
| R1 | ₹472.66 |
| PP | ₹463.83 |
| S1 | ₹451.16 |
| S2 | ₹442.33 |
| S3 | ₹429.66 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 17,588 Cr. |
| Current Price | ₹ 460 |
| High / Low | ₹ 1,039 / 267 |
| Stock P/E | 163 |
| Book Value | ₹ 102 |
| Dividend Yield | 0.00 % |
| ROCE | 5.81 % |
| ROE | 4.89 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2023 | 348 | 121 | 48% |
| Sep 2023 | 231 | 80 | 42% |
| Dec 2023 | 220 | 47 | 30% |
| Mar 2024 | 253 | 53 | 29% |
| Jun 2024 | 488 | 75 | 26% |
| Sep 2024 | 604 | 138 | 34% |
| Dec 2024 | 676 | 153 | 35% |
| Mar 2025 | 840 | 117 | 27% |
| Jun 2025 | 549 | 46 | 20% |
| Sep 2025 | 556 | 66 | 22% |
| Dec 2025 | 545 | 29 | 18% |
| Mar 2026 | 619 | 8 | 16% |
| Jun 2026 | 422 | -45 | 0.3% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 60.00% |
| FIIs | 0.00% |
| DIIs | 8.19% |
| Government | 0.00% |
| Public | 31.81% |
| No. of Shareholders | 60,684 |
Pros and Cons
Pros
- Strong technical momentum with price holding comfortably above the 50 DMA (444.87).
Cons
- Valuation metrics appear elevated with a trailing P/E of 163, demanding high performance requirements.
Related NSE Stocks
Poonawalla Fincorp Ltd.
View Share Price Analysis →Bajaj Housing Finance Ltd.
View Share Price Analysis →Cipla Ltd.
View Share Price Analysis →The Ramco Cements Ltd.
View Share Price Analysis →Sonata Software Ltd.
View Share Price Analysis →Jain Resource Recycling Ltd.
View Share Price Analysis →Hindustan Petroleum Corporation Ltd.
View Share Price Analysis →UNO Minda Ltd.
View Share Price Analysis →Nestle India Ltd.
View Share Price Analysis →UTI Asset Management Company Ltd.
View Share Price Analysis →Mangalore Refinery & Petrochemicals Ltd.
View Share Price Analysis →ZF Commercial Vehicle Control Systems India Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Cohance Lifesciences Ltd share?
Based on the latest closing data, the technical momentum for Cohance Lifesciences Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 63.17, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (444.87) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Cohance Lifesciences Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Cohance Lifesciences Ltd today centers at a Pivot Point (PP) of ₹463.83. Upside resistance challenges are calculated at R1: ₹472.66, R2: ₹485.33, and R3: ₹494.16. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹451.16, S2: ₹442.33, and S3: ₹429.66.
How does the fundamental ROE and P/E ratio look for Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd is currently trading with a valuation metrics context of a Stock P/E of 163, against a core structural efficiency Return on Equity (ROE) standing at 4.89 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 5, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Cohance Lifesciences Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Cohance Lifesciences Ltd is trading... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A+, a Relative Strength (RS) ranking of 42, and long-term trend backing from the TI65 indicator (Neutral pattern).